SEALSQ CORP (LAES)

VGG794831062 - Common Stock

7.73  -0.41 (-5.04%)

After market: 7.52 -0.21 (-2.72%)

Fundamental Rating

2

LAES gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. LAES scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LAES is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year LAES has reported negative net income.
In the past year LAES has reported a negative cash flow from operations.

1.2 Ratios

LAES's Return On Assets of -43.51% is on the low side compared to the rest of the industry. LAES is outperformed by 86.92% of its industry peers.
With a Return On Equity value of -268.49%, LAES is not doing good in the industry: 89.72% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -43.51%
ROE -268.49%
ROIC N/A
ROA(3y)-8.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LAES has a Gross Margin of 42.95%. This is comparable to the rest of the industry: LAES outperforms 43.93% of its industry peers.
In the last couple of years the Gross Margin of LAES has grown nicely.
LAES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.19%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

LAES does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LAES has been increased compared to 1 year ago.
LAES has a better debt/assets ratio than last year.

2.2 Solvency

LAES has an Altman-Z score of 16.75. This indicates that LAES is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.75, LAES belongs to the best of the industry, outperforming 85.98% of the companies in the same industry.
A Debt/Equity ratio of 3.55 is on the high side and indicates that LAES has dependencies on debt financing.
LAES has a Debt to Equity ratio of 3.55. This is amonst the worse of the industry: LAES underperforms 94.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF N/A
Altman-Z 16.75
ROIC/WACCN/A
WACC9.75%

2.3 Liquidity

LAES has a Current Ratio of 3.58. This indicates that LAES is financially healthy and has no problem in meeting its short term obligations.
LAES has a better Current ratio (3.58) than 60.75% of its industry peers.
A Quick Ratio of 3.20 indicates that LAES has no problem at all paying its short term obligations.
LAES has a Quick ratio of 3.20. This is in the better half of the industry: LAES outperforms 63.55% of its industry peers.
Industry RankSector Rank
Current Ratio 3.58
Quick Ratio 3.2

2

3. Growth

3.1 Past

The earnings per share for LAES have decreased strongly by -122.02% in the last year.
LAES shows a decrease in Revenue. In the last year, the revenue decreased by -8.07%.
The Revenue has been growing by 28.05% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-122.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-387.54%
Revenue 1Y (TTM)-8.07%
Revenue growth 3Y28.05%
Revenue growth 5YN/A
Sales Q2Q%-67.27%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LAES. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LAES!.
Industry RankSector Rank
Dividend Yield N/A

SEALSQ CORP

NASDAQ:LAES (1/6/2025, 8:00:02 PM)

After market: 7.52 -0.21 (-2.72%)

7.73

-0.41 (-5.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.6%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap755.30M
Analysts82.86
Price Target1.79 (-76.84%)
Short Float %40.69%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.65
P/FCF N/A
P/OCF N/A
P/B 144.58
P/tB 144.58
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.36
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -43.51%
ROE -268.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.95%
FCFM N/A
ROA(3y)-8.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.19%
GM growth 5YN/A
F-Score2
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 3.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 240.03%
Cap/Sales 4.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.58
Quick Ratio 3.2
Altman-Z 16.75
F-Score2
WACC9.75%
ROIC/WACCN/A
Cap/Depr(3y)201.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.85%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-387.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.07%
Revenue growth 3Y28.05%
Revenue growth 5YN/A
Sales Q2Q%-67.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-665.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-101.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-72.03%
OCF growth 3YN/A
OCF growth 5YN/A